Intravenous to Oral Antibiotic Switch Therapy Among Patients Hospitalized With Community-Acquired Pneumonia
- PMID: 37011018
- PMCID: PMC10527888
- DOI: 10.1093/cid/ciad196
Intravenous to Oral Antibiotic Switch Therapy Among Patients Hospitalized With Community-Acquired Pneumonia
Abstract
Background: Community-acquired pneumonia (CAP) is a leading cause of hospital admissions and antimicrobial use. Clinical practice guidelines recommend switching from intravenous (IV) to oral antibiotics once patients are clinically stable.
Methods: We conducted a retrospective cohort study of adults admitted with CAP and initially treated with IV antibiotics at 642 US hospitals from 2010 through 2015. Switching was defined as discontinuation of IV and initiation of oral antibiotics without interrupting therapy. Patients switched by hospital day 3 were considered early switchers. We compared length of stay (LOS), in-hospital 14-day mortality, late deterioration (intensive care unit [ICU] transfer), and hospital costs between early switchers and others, controlling for hospital characteristics, patient demographics, comorbidities, initial treatments, and predicted mortality.
Results: Of 378 041 CAP patients, 21 784 (6%) were switched early, most frequently to fluoroquinolones. Patients switched early had fewer days on IV antibiotics, shorter duration of inpatient antibiotic treatment, shorter LOS, and lower hospitalization costs, but no significant excesses in 14-day in-hospital mortality or late ICU admission. Patients at a higher mortality risk were less likely to be switched. However, even in hospitals with relatively high switch rates, <15% of very low-risk patients were switched early.
Conclusions: Although early switching was not associated with worse outcomes and was associated with shorter LOS and fewer days on antibiotics, it occurred infrequently. Even in hospitals with high switch rates, <15% of very low-risk patients were switched early. Our findings suggest that many more patients could be switched early without compromising outcomes.
Keywords: IV to oral; antimicrobial stewardship; community-acquired pneumonia; switch therapy.
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Conflict of interest statement
Conflict of interest. A. D. reports research funding (to institution) from the Clorox Company, consultant fees from Merck, and grants or contracts to institution, unrelated to the current study, from Seres Therapeutics. M. K. reports royalties from UpToDate and grants or contracts to institution from the Centers for Disease Control and Prevention and the Agency for Healthcare Research and Quality. M. D. Z. reports research support from Tetraphase Pharmaceuticals, Astellas, Lungpacer, Merck, Spero, Medicines Co, Melinta, scPharma, Shionogi, and Pfizer; consulting fees from Paratek, Arasanis, Shionogi, Pfizer, Nabriva, scPharma, and Melinta; and stock or stock options from Johnson & Johnson. T. H. reports consulting fees from the Cerner Corporation. P. B. I. reports consulting fees from Colgate-Palmolive. S. H. reports a role with the Society for Health Epidemiology of America (councilor, board of trustees, volunteer; no compensation). All remaining authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Figures




Similar articles
-
Association Between Initial Route of Fluoroquinolone Administration and Outcomes in Patients Hospitalized for Community-acquired Pneumonia.Clin Infect Dis. 2016 Jul 1;63(1):1-9. doi: 10.1093/cid/ciw209. Epub 2016 Apr 5. Clin Infect Dis. 2016. PMID: 27048748 Free PMC article.
-
Switching from intravenous to oral antibiotics in hospitalized patients with community-acquired pneumonia: A real-world analysis 2010-2018.J Infect Chemother. 2020 Jul;26(7):706-714. doi: 10.1016/j.jiac.2020.03.010. Epub 2020 Apr 10. J Infect Chemother. 2020. PMID: 32284180
-
Community-acquired pneumonia team decreases length of stay in hospitalized, low-risk patients with pneumonia.Hosp Pract (1995). 2013 Aug;41(3):7-14. doi: 10.3810/hp.2013.08.1063. Hosp Pract (1995). 2013. PMID: 23948616
-
Strategies for early discharge of the hospitalized patient with community-acquired pneumonia.Clin Chest Med. 1999 Sep;20(3):599-605. doi: 10.1016/s0272-5231(05)70239-2. Clin Chest Med. 1999. PMID: 10516907 Review.
-
Duration and route of antibiotic therapy in community-acquired pneumonia: switch and step-down therapy.Semin Respir Infect. 1998 Mar;13(1):36-42. Semin Respir Infect. 1998. PMID: 9543474 Review.
Cited by
-
Point prevalence survey of antibiotic use in Mexican secondary care hospitals.PLoS One. 2025 Jan 3;20(1):e0315925. doi: 10.1371/journal.pone.0315925. eCollection 2025. PLoS One. 2025. PMID: 39752460 Free PMC article.
-
A Rare Case of Cold Agglutinin Syndrome Associated With Legionella Pneumonia.Cureus. 2023 Jul 3;15(7):e41310. doi: 10.7759/cureus.41310. eCollection 2023 Jul. Cureus. 2023. PMID: 37539399 Free PMC article.
-
Efficacy and Safety of Intravenous-to-Oral Lascufloxacin Switch Therapy in Community-Onset Pneumonia: A Single-Arm, Open-Label Clinical Trial.Cureus. 2025 Mar 11;17(3):e80404. doi: 10.7759/cureus.80404. eCollection 2025 Mar. Cureus. 2025. PMID: 40078884 Free PMC article.
-
Transitioning to oral therapy compared to IV in Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis.Ann Med Surg (Lond). 2025 Jan 9;87(1):265-275. doi: 10.1097/MS9.0000000000002742. eCollection 2025 Jan. Ann Med Surg (Lond). 2025. PMID: 40109636 Free PMC article.
-
Acceptance of pharmacist-led stewardship recommendations for patients with community-acquired pneumonia.Antimicrob Steward Healthc Epidemiol. 2024 Oct 17;4(1):e181. doi: 10.1017/ash.2024.399. eCollection 2024. Antimicrob Steward Healthc Epidemiol. 2024. PMID: 39450099 Free PMC article.
References
-
- Williams S, Gousen S, DeFrances C. National Hospital Care Survey demonstration projects: pneumonia inpatient hospitalizations and emergency department visits. Natl Health Stat Report 2018; 116:1–11. - PubMed
-
- Brown K, Valenta K, Fisman D, Simor A, Daneman N. Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection. JAMA Intern Med 2015; 175:626–33. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous